From Inflammation to the Onset of Fibrosis through A2A Receptors in Kidneys from Deceased Donors

Int J Mol Sci. 2020 Nov 21;21(22):8826. doi: 10.3390/ijms21228826.

Abstract

Pretransplant graft inflammation could be involved in the worse prognosis of deceased donor (DD) kidney transplants. A2A adenosine receptor (A2AR) can stimulate anti-inflammatory M2 macrophages, leading to fibrosis if injury and inflammation persist. Pre-implantation biopsies of kidney donors (47 DD and 21 living donors (LD)) were used to analyze expression levels and activated intracellular pathways related to inflammatory and pro-fibrotic processes. A2AR expression and PKA pathway were enhanced in DD kidneys. A2AR gene expression correlated with TGF-β1 and other profibrotic markers, as well as CD163, C/EBPβ, and Col1A1, which are highly expressed in DD kidneys. TNF-α mRNA levels correlated with profibrotic and anti-inflammatory factors such as TGF-β1 and A2AR. Experiments with THP-1 cells point to the involvement of the TNF-α/NF-κB pathway in the up-regulation of A2AR, which induces the M2 phenotype increasing CD163 and TGF-β1 expression. In DD kidneys, the TNF-α/NF-κB pathway could be involved in the increase of A2AR expression, which would activate the PKA-CREB axis, inducing the macrophage M2 phenotype, TGF-β1 production, and ultimately, fibrosis. Thus, in inflamed DD kidneys, an increase in A2AR expression is associated with the onset of fibrosis, which may contribute to graft dysfunction and prognostic differences between DD and LD transplants.

Keywords: adenosine receptor; fibrosis; inflammation; kidney; macrophage; purinome; transplant.

MeSH terms

  • Cyclic AMP Response Element-Binding Protein / genetics*
  • Cyclic AMP-Dependent Protein Kinases / genetics*
  • Fibrosis / genetics
  • Fibrosis / pathology
  • Fibrosis / therapy
  • Gene Expression Regulation / genetics
  • Humans
  • Inflammation / genetics
  • Inflammation / pathology
  • Inflammation / therapy
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Transplantation*
  • Macrophages / metabolism
  • Macrophages / pathology
  • NF-kappa B / genetics
  • Receptor, Adenosine A2A / genetics*
  • Tissue Donors
  • Transforming Growth Factor beta1 / genetics
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • ADORA2A protein, human
  • CREB1 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • NF-kappa B
  • Receptor, Adenosine A2A
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha
  • Cyclic AMP-Dependent Protein Kinases